Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Чобанова Алєксандра Ангєлова, Чобанова Александра АнгеловаfiledCriticalЧобанова Алєксандра Ангєлова
Priority claimed from PCT/BG1996/000003external-prioritypatent/WO1997015590A1/en
Publication of UA28084C2publicationCriticalpatent/UA28084C2/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Inventions relates to the medicine, in particular to an antitumoral substances from a mucous intestine and method of their selection. The antitumoral substance, separated from mucous thin intestine, represents two nucleopeptides - inhibiting enterocytogenins (IEG), where IEG 1 is a peptide with molecular weight up to 4.450+0.180 кDа, bounded with two guanylic residues and containing 2 Thr (Threonin), 4 Glu (Glutamic acid), 5 Gly (Glycine), 2 Asp (Aspartic acid), 2 Ser (Serine), 4 Ala (Lactamic acid), 2 Val (Valyn), 1 He (Isoleucine), 1 Try (Tryptophane), 3 Lys (Lysine), 1 His (Histidine), 1 Arg (Arginine), 2 Leu (Leucine), 3 Pro (Proline)
UA97062838A1995-10-201996-03-04Antitumoral agent, isolated from intestine mucous membrane, method of its isolation
UA28084C2
(en)
Dissociation of bovine 6S procarboxypeptidase A by reversible condensation with 2, 3-dimethyl maleic anhydride: application to the partial characterization of subunit III.
Isolation of endopeptidase-24.11 (EC 3.4. 24.11,“enkephalinase”) from the pig stomach: Hydrolysis of substance P, gastrin-releasing peptide 10,[Leu5] enkephalin, and [Met5] enkephalin